Press Archive - Arriello

Pharmacovigilance audits. What inspectors want.

Many life sciences companies are still struggling with pharmacovigilance audits and inspections. Arriello's Vanessa Fachada Oliveira highlights key areas of focus for MAHs to achieve an effective audit of their PV systems.

Are Regulatory Service providers over-estimating AI's potential?

Advanced digital tools are certain to play a pivotal role in the redesign of labour-intensive regulatory processes, but there is a danger that AI's potential contribution is being over-hyped to life sciences firms.
Arriello's CEO Alan White warns that the key to ROI is in the application...

Automating PV Data Capture: What's stopping Companies?

Proven solutions exist now which could transform the efficiency, effectiveness and regulatory adherence of PV processes, without placing data at any risk of being compromised in any way. By John Price – Pharmacovigilance expert and advisor to Arriello.

Maintaining Control: The importance of project management.

In process outsourcing, it's easy to neglect the role of formal project management to keep delivery on track; unless it's clinical research, biotech or pharma organisations commonly neglect this when transferring a service externally.

Overcoming 5 barriers to process automation in PV.

What is stopping automation in PV. The case for automation in Pharmacovigilance, is strong. Arriello's Peter Kohut, suggests a way forward...

The challenges of delivering medicinal information online.

In the light of new ePI guidelines in Europe for medicinal products, Irena Milobratovic, senior regulatory affairs manager at Arriello, considers the benefits and challenges associated with providing current product and safety information to patients and healthcare professionals via the web.